EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clostridium butyricum inhibits epithelial–mesenchymal transition of intestinal carcinogenesis through downregulating METTL3

Kexin Zhang, Yue Dong, Mengfan Li, Wanru Zhang, Yiyun Ding, Xin Wang, Danfeng Chen, Tianyu Liu, Bangmao Wang, Hailong Cao iD, Weilong Zhong

Cancer Science · 2023

DOI: 10.1111/cas.15839 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Kexin Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, National Key Clinical Specialty, Tianjin Institute of Di…. Hauptthemen laut MEDLINE: Clostridium butyricum, Colorectal Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Key Project of Science and Technology Pillar Program of Tianjin, Tianjin Key Medical Discipline (Specialty) Construction Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is related to gut microbiota dysbiosis, especially butyrate‐producing bacteria reduction. Our previous study suggested that administration of Clostridium butyricum , a butyrate‐producing bacterium, exerts a crucial effect against CRC, however the potential mechanism is not clear. We first found that methyltransferase‐like 3 (METTL3) showed a positive correlation with proliferation, epithelial–mesenchymal transition (EMT), DNA repair, metastasis, and invasion in a database analysis. The expression of METTL3 gradually increased from human normal colon tissue, to adenoma, and carcinoma, and was positively correlated with E‐cadherin and CD34 levels. Overexpression of METTL3 promoted the proliferation, migration, and invasion of CRC cells and induced vasculogenic mimicry (VM) formation. Clostridium butyricum could downregulate METTL3 expression in CRC cells and decrease the expression of vimentin and vascular endothelial growth factor receptor 2 to reduce EMT and VM formation. Clostridium butyricum alleviated the pro‐oncogenic effect of METTL3 overexpressing plasmid in CRC cells. The anti‐EMT effect on METTL3 reduction of C. butyricum could be blunted by knocking down G‐protein coupled receptor 43. Moreover, C. butyricum prevented EMT and VM and inhibited tumor metastasis in nude mice. Accordingly, C. butyricum could inhibit EMT and VM formation of intestinal carcinogenesis through downregulating METTL3. These findings broaden our understanding of probiotics supplement in CRC prevention and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridium butyricumColorectal NeoplasmsAnimalsMiceHumansEpithelial-Mesenchymal TransitionVascular Endothelial Growth Factor AMice, NudeButyratesCarcinogenesisCell Line, TumorCell MovementMethyltransferases

Stichwörter der Autor:innen

Clostridium butyricumcolorectal cancerepithelial-mesenchymal transitionmethyltransferase-like 3vasculogenic mimicry

Substanzen

Vascular Endothelial Growth Factor AButyratesMETTL3 protein, humanMethyltransferases

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, National Key Clinical Specialty, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianji…

ORCID-Profile: Hailong Cao

Förderung

  • National Natural Science Foundation of China
  • Key Project of Science and Technology Pillar Program of Tianjin
  • Tianjin Key Medical Discipline (Specialty) Construction Project

Zitieren

APA

Zhang, K., Dong, Y., Li, M., Zhang, W., Ding, Y., Wang, X., Chen, D., Liu, T., Wang, B., Cao, H., & Zhong, W. (2023). Clostridium butyricum inhibits epithelial–mesenchymal transition of intestinal carcinogenesis through downregulating METTL3. Cancer Science. https://doi.org/10.1111/cas.15839

Vancouver

Zhang K, Dong Y, Li M, Zhang W, Ding Y, Wang X, et al. Clostridium butyricum inhibits epithelial–mesenchymal transition of intestinal carcinogenesis through downregulating METTL3. Cancer Science. 2023. doi:10.1111/cas.15839

BibTeX
@article{Zhang2023,
  author = {Zhang, Kexin and Dong, Yue and Li, Mengfan and Zhang, Wanru and Ding, Yiyun and Wang, Xin and Chen, Danfeng and Liu, Tianyu and Wang, Bangmao and Cao, Hailong and Zhong, Weilong},
  title = {Clostridium butyricum inhibits epithelial–mesenchymal transition of intestinal carcinogenesis through downregulating METTL3},
  journal = {Cancer Science},
  year = {2023},
  doi = {10.1111/cas.15839}
}
Kostenlos starten →